Stock Analysis
- United States
- /
- Life Sciences
- /
- NasdaqCM:CYRX
Insiders Sold Cryoport At US$13.99, Meanwhile Stock Sits Near US$6.96
Cryoport, Inc.'s (NASDAQ:CYRX) value has fallen 15% in the last week, but insiders who sold US$301k worth of stock over the last year have had less success. Given that the average selling price of US$13.99 is still lower than the current share price, insiders would probably have been better off keeping their shares.
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
View our latest analysis for Cryoport
The Last 12 Months Of Insider Transactions At Cryoport
The Independent Lead Director, Richard Jay Berman, made the biggest insider sale in the last 12 months. That single transaction was for US$109k worth of shares at a price of US$13.41 each. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The good news is that this large sale was at well above current price of US$6.96. So it is hard to draw any strong conclusion from it.
Cryoport insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
I will like Cryoport better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.
Insiders At Cryoport Have Sold Stock Recently
The last three months saw some Cryoport insider selling. Independent Director Robert Hariri divested only US$27k worth of shares in that time. It's not great to see insider selling, nor the lack of recent buyers. But the amount sold isn't enough for us to put any weight on it.
Insider Ownership Of Cryoport
Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 2.4% of Cryoport shares, worth about US$9.4m, according to our data. Whilst better than nothing, we're not overly impressed by these holdings.
So What Do The Cryoport Insider Transactions Indicate?
While there has not been any insider buying in the last three months, there has been selling. But given the selling was modest, we're not worried. Recent sales exacerbate our caution arising from analysis of Cryoport insider transactions. And usually insiders own more stock in the company, according to our data. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Cryoport. To assist with this, we've discovered 2 warning signs that you should run your eye over to get a better picture of Cryoport.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:CYRX
Cryoport
Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.